ALKERMES, INC.

🇺🇸United States
Ownership
Subsidiary
Employees
-
Market Cap
-
Website
http://www.alkermes.com

ALK21-018: Effects of Medisorb® Naltrexone (VIVITROL®) on Alcohol Craving in Treatment-seeking, Alcohol-dependent Adults

Phase 4
Completed
Conditions
Interventions
First Posted Date
2007-08-06
Last Posted Date
2017-07-11
Lead Sponsor
Alkermes, Inc.
Target Recruit Count
31
Registration Number
NCT00511836
Locations
🇺🇸

McLean Hospital, Belmont, Massachusetts, United States

ALK21-014: Efficacy and Safety of Medisorb® Naltrexone (VIVITROL®) After Enforced Abstinence

First Posted Date
2007-07-16
Last Posted Date
2011-09-22
Lead Sponsor
Alkermes, Inc.
Target Recruit Count
300
Registration Number
NCT00501631

ALK21-010: Long-term Safety of Medisorb® Naltrexone (VIVITROL®) in Alcohol-dependent Adults

First Posted Date
2005-09-12
Last Posted Date
2017-07-11
Lead Sponsor
Alkermes, Inc.
Target Recruit Count
108
Registration Number
NCT00156923

The Safety and Effectiveness of RMP-7 Plus Amphotericin B in Patients With HIV and Cryptococcal Meningitis

Phase 1
Completed
Conditions
First Posted Date
2001-08-31
Last Posted Date
2005-06-24
Lead Sponsor
Alkermes, Inc.
Registration Number
NCT00002316
Locations
🇺🇸

SUNY / Health Sciences Ctr at Stony Brook, Stony Brook, New York, United States

🇺🇸

Pennsylvania State Univ / Hershey Med Ctr, Hershey, Pennsylvania, United States

🇺🇸

Los Angeles County - USC Med Ctr, Los Angeles, California, United States

and more 8 locations
© Copyright 2024. All Rights Reserved by MedPath